Funded startups in South San Francisco, California
12 startups in South San Francisco, California have filed a Form D with the SEC and together report $731M raised. NGM Bio has the largest latest round, at $142M. Amounts are as reported on the filing, not estimates.
Latest filing Jun 10, 2026
- Companies
- 12
- Total raised
- $731.0M
- Filings
- 13
- Median round
- $60.0M
Most recent filings
12Lycia TherapeuticsBiotechExtracellular protein degraders for immune diseases
Jun 10, 2026
$75.0M
SonoTheraBiotechUltrasound-delivered gene therapies without viral vectors
Jun 8, 2026
$125.5M
Senti BiosciencesBiotechGene medicines whose dose can be tuned after treatment
May 20, 2026
$10.0M
Quince TherapeuticsBiotechDrugs encapsulated in a patient's own red blood cells
May 18, 2026
—
Terremoto BiosciencesBiotechSelective AKT1 inhibitors for breast cancer and solid tumors
Apr 10, 2026
$40.7M
Olden LabsBiotechAI smart cages that monitor lab rodents around the clock
Mar 13, 2026
$6.5M
GlydwaysRoboticsAutonomous small-vehicle transit on dedicated guideways
Feb 25, 2026
$60.0M
SurrozenBiotechWnt-activating antibodies for tissue repair
Mar 26, 2025
$76.4M
SynlicoBiotechEngineered T cell therapies for solid tumors
Feb 24, 2025
$3.0M
Long Bridge MedicalHealthcareCatheter system for complex coronary lesions
Nov 15, 2024
$1.0M
NGM BioBiotechAntibody drugs for pregnancy nausea and cancer wasting
Jul 5, 2024
$142.0M
Quanta TherapeuticsBiotechOral KRAS G12D and G12V inhibitors for cancer
May 10, 2023
$76.2M
All 12 companies · most recent filing first